Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor.

H. Kantarjian, AB Deisseroth, Dimitrios P. Kontoyiannis et al.|Journal of Clinical Oncology|1992

Cited by 65